PharmaNutra

PHN · Borsa Italiana · EUR

70,50 €Variation par rapport à la clôture précédente: −0,98 %Variation absolue: −0,70 €

Clôture · 2 octobre 2026

Profil de la société

Pharmanutra S.p.A., a nutraceutical company, engages in the research and development and marketing of food supplements and medical devices in Europe, the Middle East, Far East, North America, South America, and internationally. The company produces and distributes raw materials and active ingredients for the food, pharmaceutical, and dietary supplement industries. It offers Sucrosomial, a delivery system that optimises nutrient transport and absorption for minimising gastrointestinal side effects; and Cetylated Fatty Acids, a formulation for muscle and joint recovery in physiotherapy and sports. The company also sells instrumentation and software for body bioimpedance analysis through agents, distributors, and online sales. Pharmanutra S.p.A. was founded in 2000 and is headquartered in Pisa, Italy.

Description disponible en anglais.

Informations sur la société

Secteur
Santé
Industrie
Drug Manufacturers - Specialty & Generic
Pays
Italie
Siège
Via Campodavela 1, 56122, Pisa
Salariés
144
Cotation
PHN · Borsa Italiana
Devise
EUR
ISIN
IT0005274094